The FDA’s full approval of the Pfizer COVID-19 vaccine could spark two major impacts, experts say: more vaccine-hesitant people willing to get the shot and more companies and institutions implementing mandates to those not yet inoculated.

"I think that the validation as the FDA has just created today in giving it full approval and a license is going to make it more palatable, not for everybody, but for more people," said Dr. Jay Wolfson, professor of public health and vice president for health law, policy and safety at the University of South Florida.

MORE: [ Ссылка ]

►Subscribe: [ Ссылка ]
►Website: [ Ссылка ]
►Facebook: [ Ссылка ]
►Twitter: [ Ссылка ]

свернуть